(UroToday.com) The ASCO 2020 Virtual Education Program featured a session highlighting molecular enrichment strategies in genitourinary cancer, including Bradley McGregor, MD, discussing biomarker-driven strategies for renal cell cancer. Dr. McGregor notes that there are prognostic biomarkers that identify patients more likely to have a particular outcome, and there are predictive biomarkers that predict a favorable or unfavorable effect from an exposure.